Mark Rothera

CIK 1550424 · President and CEO · last filed 2024-03-13

Mark Rothera is a President and CEO who has filed 28 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing, for VIRX, was dated Mar 13, 2024. Across all open-market trades the lifetime net is −$4.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.23M

Companies

3

Total Filings

28

Lifetime Open-Market Net

-$4.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Viracta Therapeutics, Inc. (VIRX) Delisted President and CEO 52,094 $0.01 $511 $49.4K 4 2024-03-13
PTCT Chief Commercial Officer 42,955 $75.14 $3.23M -$4.72M 23 2017-05-25
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Global President $0 1 2012-06-05

Recent Filings

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-03-13 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) $0 EDGAR
2023-12-04 Viracta Therapeutics, Inc. (VIRX) Delisted Buy (P) +100,000 $49.4K EDGAR
2023-03-17 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) $0 EDGAR
2022-09-19 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) $0 EDGAR
2017-05-25 PTCT Exer (M) +2,000 $21.7K EDGAR
2017-03-17 PTCT Exer (M) +2,966 $32.2K EDGAR
2017-02-17 PTCT Exer (M) +3,125 $33.9K EDGAR
2017-01-17 PTCT Exer (M) +3,125 $33.9K EDGAR
2017-01-05 PTCT Grant (A) +9,600 $0 EDGAR
2016-11-14 PTCT Exer (M) +1,941 $21.1K EDGAR
Showing 110 of 28
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.